GACL FY26 PAT rises 32% to ₹208 crore, recommends dividend

2 min read     Updated on 31 May 2026, 07:11 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Gujarat Alkalies and Chemicals reported a 32% rise in FY26 PAT to ₹208 crore, driven by a 7% revenue increase to ₹4,358 crore. The Board recommended a final dividend of ₹17.70 per share. While standalone results improved, consolidated figures showed a net loss of ₹241 crore, narrowed from the previous year, due to losses in its joint venture. The company approved a ₹67 crore investment in a new hydrogen peroxide plant and other strategic initiatives.

powered bylight_fuzz_icon
41591752

*this image is generated using AI for illustrative purposes only.

Gujarat Alkalies and Chemicals reported a 32% increase in profit after tax (PAT) to ₹208 crore for the financial year ended March 31, 2026, compared to ₹158 crore in the previous year. Revenue from operations rose 7% to ₹4,358 crore from ₹4,073 crore in FY25. The Board of Directors approved the audited financial results for the fourth quarter and full year at meetings held on May 28 and May 29, 2026, under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance and Dividend

The Board recommended a final dividend of ₹17.70 per equity share, or 177%, for the year ended March 31, 2026. The total dividend outgo amounts to ₹1,299.83 crore on 7,34,36,928 equity shares of ₹10 each. The statutory auditors audited the financial results, which were reviewed by the Audit Committee. The company's EBITDA for the year increased by 15% to ₹522 crore, driven by higher capacity utilization and improved sales realizations.

Consolidated Results and Joint Venture

The consolidated financial results for FY26 reported a net loss of ₹241 crore, compared to a net loss of ₹651 crore in the previous year. The consolidated figures include the results of joint venture company GACL-NALCO Alkalies & Chemicals Pvt. Ltd. (60%) and 26% of associates. The joint venture incurred losses of ₹386.87 crore during the year, with accumulated losses of ₹6,333.08 crore as of March 31, 2026. An external expert assessment determined that no impairment provision is required against the company's investment of ₹4,140 crore in the joint venture, as the fair value exceeds the carrying amount.

Capital Expenditure and Strategic Initiatives

The Board approved the establishment of a 5000 TPA High Purity Grade Hydrogen Peroxide Plant at Dahej, Gujarat, with an estimated investment of ₹67 crore. The project is scheduled to be commissioned in 18 months and is expected to contribute approximately ₹42 crore to annual sales revenue. The facility aims to serve niche applications in semiconductor fabrication, solar cell manufacturing, and advanced electronics. Funding will be sourced from internal accruals, with need-based gaps met through borrowings.

Financial Metric FY26 (₹ in Lakhs) FY25 (₹ in Lakhs)
Revenue from Operations 4,35,808 4,07,291
Profit for the Period 2,084 1,582
Total Income 4,47,470 4,16,505
Earnings Per Share (Basic) 2.84 2.15

The Board also approved the remembrancing and recoating of generation VB+ Cell elements at the Vadodara Complex to reduce power costs and the implementation of a digitization and AI strategy, including migration to SAP S/4HANA. For the current financial year, the company expects to commission several projects, including an HCl Synthesis Unit and 138.60 MW of renewable energy projects.

Historical Stock Returns for Gujarat Alkalies & Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.79%-3.19%-16.92%+27.12%+14.39%+63.48%

What strategies will GACL implement to turn around the joint venture's performance given its substantial accumulated losses?

How will the commissioning of 138.60 MW of renewable energy projects impact the company's power costs and EBITDA margins in the coming year?

Will the company pursue further expansion into high-purity chemicals for the semiconductor sector following the new Hydrogen Peroxide plant investment?

Gujarat Alkalies & Chemicals
View Company Insights
View All News
like20
dislike

Gujarat Alkalies launches Saksham Niveshak campaign for KYC

1 min read     Updated on 26 May 2026, 05:46 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Gujarat Alkalies and Chemicals Limited has launched the Second 100 days Campaign - Saksham Niveshak to assist shareholders in updating KYC details and claiming unpaid dividends for financial years 2018-19 to 2025-26. The initiative aims to prevent the transfer of unclaimed funds to the IEPF. Shareholders must submit specific forms to MUFG Intime India Private Limited, with dividends paid only via electronic mode after verification.

powered bylight_fuzz_icon
41264354

*this image is generated using AI for illustrative purposes only.

Gujarat Alkalies and Chemicals Limited has commenced the Second 100 days Campaign - Saksham Niveshak to facilitate the updation of KYC details and the claiming of unpaid dividends. This initiative follows a circular from the Investor Education and Protection Fund Authority (IEPFA) and the Ministry of Corporate Affairs (MCA) dated July 16, 2025. The primary objective is to prevent the transfer of unpaid or unclaimed dividends to the IEPF by ensuring shareholders update their records and claim their entitlements.

The company has communicated that shareholders with unpaid dividends for any financial years from 2018-19 to 2025-26 must act to secure their funds. The campaign specifically targets those holding shares in physical or demat form who have not updated details such as PAN, nomination details, postal address, mobile number, email address, bank account details, and specimen signature. The company has previously utilized email communications, newspaper advertisements, and letters to inform shareholders about these requirements.

Documentation Requirements

Shareholders are required to submit specific forms and documents based on their mode of holding. For physical shares, the company mandates the submission of self-attested KYC documents along with specific forms, while demat holders must update details directly with their Depository Participant.

Type of Holding Documents to be Submitted
Shares held in Physical Form Form ISR-1 (filed and signed, with self-attested KYC documents); Form ISR-2 (filed and signed, with Banker’s attested Bank Passbook/Statement); Form SH-13 (for adding a Nominee); Form ISR-3 (to opt out of nomination)
Shares held in Demat form Update KYC details with your Depository Participant

Submission Process

Documents must be submitted to the company’s Registrar and Transfer Agent, MUFG Intime India Private Limited. Shareholders can send self-attested physical copies by post to the Vadodara address or email digitally signed documents from their registered email ID. In cases of joint holdings, the first joint holder must sign the documents.

The company emphasized that dividends are payable only through electronic mode. Consequently, the amount will be credited to the shareholder’s bank account only after the required information and documents are successfully updated. Shareholders facing issues related to unclaimed dividends and shares may also contact their respective Depository Participants or the company directly.

Historical Stock Returns for Gujarat Alkalies & Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.79%-3.19%-16.92%+27.12%+14.39%+63.48%

How will the success of the Saksham Niveshak campaign impact Gujarat Alkalies and Chemicals' future shareholder engagement strategies?

Could this initiative by Gujarat Alkalies set a precedent for other companies facing similar regulatory pressure from the IEPFA?

What are the potential financial implications for the company if a significant portion of unpaid dividends remains unclaimed and is transferred to the IEPF?

Gujarat Alkalies & Chemicals
View Company Insights
View All News
like20
dislike

More News on Gujarat Alkalies & Chemicals

1 Year Returns:+14.39%